BIOTIME (Germany) Performance
| BT3 Stock | EUR 1.35 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.031, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BIOTIME's returns are expected to increase less than the market. However, during the bear market, the loss of holding BIOTIME is expected to be smaller as well. At this point, BIOTIME has a negative expected return of -0.18%. Please make sure to confirm BIOTIME's information ratio, total risk alpha, potential upside, as well as the relationship between the jensen alpha and value at risk , to decide if BIOTIME performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days BIOTIME has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Last Split Factor 1:3 | Last Split Date 2019-11-25 |
| Begin Period Cash Flow | 36 M | |
| Free Cash Flow | -23.7 M |
BIOTIME |
BIOTIME Relative Risk vs. Return Landscape
If you would invest 154.00 in BIOTIME on November 6, 2025 and sell it today you would lose (19.00) from holding BIOTIME or give up 12.34% of portfolio value over 90 days. BIOTIME is producing return of less than zero assuming 2.9005% volatility of returns over the 90 days investment horizon. Simply put, 26% of all stocks have less volatile historical return distribution than BIOTIME, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BIOTIME Target Price Odds to finish over Current Price
The tendency of BIOTIME Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.35 | 90 days | 1.35 | about 84.69 |
Based on a normal probability distribution, the odds of BIOTIME to move above the current price in 90 days from now is about 84.69 (This BIOTIME probability density function shows the probability of BIOTIME Stock to fall within a particular range of prices over 90 days) .
BIOTIME Price Density |
| Price |
Predictive Modules for BIOTIME
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BIOTIME. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BIOTIME Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BIOTIME is not an exception. The market had few large corrections towards the BIOTIME's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BIOTIME, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BIOTIME within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 0.03 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | -0.04 |
BIOTIME Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BIOTIME for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BIOTIME can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BIOTIME generated a negative expected return over the last 90 days | |
| BIOTIME may become a speculative penny stock | |
| BIOTIME has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 9.5 M. Net Loss for the year was (18.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BIOTIME generates negative cash flow from operations |
BIOTIME Fundamentals Growth
BIOTIME Stock prices reflect investors' perceptions of the future prospects and financial health of BIOTIME, and BIOTIME fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIOTIME Stock performance.
| Current Valuation | 267.41 M | ||||
| Price To Book | 16.72 X | ||||
| Price To Sales | 34.14 X | ||||
| Revenue | 9.5 M | ||||
| EBITDA | (48.34 M) | ||||
| Net Income | (18.61 M) | ||||
| Total Debt | 36.21 M | ||||
| Cash Flow From Operations | (23.09 M) | ||||
| Total Asset | 113.22 M | ||||
| Retained Earnings | (403.46 M) | ||||
About BIOTIME Performance
By analyzing BIOTIME's fundamental ratios, stakeholders can gain valuable insights into BIOTIME's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIOTIME has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIOTIME has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BIOTIME is entity of Germany. It is traded as Stock on BE exchange.Things to note about BIOTIME performance evaluation
Checking the ongoing alerts about BIOTIME for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIOTIME help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BIOTIME generated a negative expected return over the last 90 days | |
| BIOTIME may become a speculative penny stock | |
| BIOTIME has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 9.5 M. Net Loss for the year was (18.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BIOTIME generates negative cash flow from operations |
- Analyzing BIOTIME's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIOTIME's stock is overvalued or undervalued compared to its peers.
- Examining BIOTIME's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIOTIME's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIOTIME's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIOTIME's stock. These opinions can provide insight into BIOTIME's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BIOTIME Stock analysis
When running BIOTIME's price analysis, check to measure BIOTIME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOTIME is operating at the current time. Most of BIOTIME's value examination focuses on studying past and present price action to predict the probability of BIOTIME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOTIME's price. Additionally, you may evaluate how the addition of BIOTIME to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |